IBDEI0Z6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16529,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16529,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,16529,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,16530,0)
 ;;=I42.7^^67^760^3
 ;;^UTILITY(U,$J,358.3,16530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16530,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/External Agent
 ;;^UTILITY(U,$J,358.3,16530,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,16530,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,16531,0)
 ;;=I21.3^^67^760^14
 ;;^UTILITY(U,$J,358.3,16531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16531,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,16531,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,16531,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,16532,0)
 ;;=I25.5^^67^760^8
 ;;^UTILITY(U,$J,358.3,16532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16532,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,16532,1,4,0)
 ;;=4^I25.5
 ;;^UTILITY(U,$J,358.3,16532,2)
 ;;=^5007115
 ;;^UTILITY(U,$J,358.3,16533,0)
 ;;=I25.9^^67^760^6
 ;;^UTILITY(U,$J,358.3,16533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16533,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16533,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,16533,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,16534,0)
 ;;=I25.10^^67^760^2
 ;;^UTILITY(U,$J,358.3,16534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16534,1,3,0)
 ;;=3^Athscl Hrt Dis Ntv Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,16534,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,16534,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,16535,0)
 ;;=D64.9^^67^760^1
 ;;^UTILITY(U,$J,358.3,16535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16535,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16535,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,16535,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,16536,0)
 ;;=I42.9^^67^760^4
 ;;^UTILITY(U,$J,358.3,16536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16536,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,16536,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,16536,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,16537,0)
 ;;=I67.9^^67^760^5
 ;;^UTILITY(U,$J,358.3,16537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16537,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16537,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,16537,2)
 ;;=^5007389
 ;;^UTILITY(U,$J,358.3,16538,0)
 ;;=F04.^^67^761^2
 ;;^UTILITY(U,$J,358.3,16538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16538,1,3,0)
 ;;=3^Amnestic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16538,1,4,0)
 ;;=4^F04.
 ;;^UTILITY(U,$J,358.3,16538,2)
 ;;=^5003051
 ;;^UTILITY(U,$J,358.3,16539,0)
 ;;=F05.^^67^761^3
 ;;^UTILITY(U,$J,358.3,16539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16539,1,3,0)
 ;;=3^Delirium d/t Phsyiological Condition
 ;;^UTILITY(U,$J,358.3,16539,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,16539,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,16540,0)
 ;;=F06.8^^67^761^6
 ;;^UTILITY(U,$J,358.3,16540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16540,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16540,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,16540,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,16541,0)
 ;;=F32.9^^67^761^5
 ;;^UTILITY(U,$J,358.3,16541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16541,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,16541,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,16541,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,16542,0)
 ;;=R41.82^^67^761^1
 ;;^UTILITY(U,$J,358.3,16542,1,0)
 ;;=^358.31IA^4^2
